Stockscreener 앱 받기
6.31
2.92%
-0.19
시간 외 거래:
6.31
전일 마감가:
$6.50
열려 있는:
$6.46
하루 거래량:
15,998
Relative Volume:
0.23
시가총액:
$51.01M
수익:
$32.03M
순이익/손실:
$-13.97M
주가수익비율:
-3.7362
EPS:
-1.6889
순현금흐름:
$-8.25M
1주 성능:
+0.40%
1개월 성능:
+0.96%
6개월 성능:
+25.45%
1년 성능:
+4.82%
1일 변동 폭
$6.26
$6.55
1주일 범위
$6.26
$7.04
52주 변동 폭
$4.16
$8.64
Electrocore Inc Stock (ECOR) Company Profile
명칭
Electrocore Inc
전화
973-290-0097
주소
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
6.31 | 52.54M | 32.03M | -13.97M | -8.25M | -1.6889 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-14 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-11-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-05-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-05-09 | 개시 | Noble Capital Markets | Outperform |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Electrocore Inc 주식(ECOR)의 최신 뉴스
ElectroCore (ECOR) moves 7.1% higher: Will this strength last? - MSN
electroCore (NASDAQ:ECOR) Director Daniel Goldberger Sells 16,072 Shares - MarketBeat
electroCore (ECOR) COO receives 70,000-share RSU equity grant - Stock Titan
electroCore (ECOR) ex-officer sells 16,072 shares to cover RSU tax - Stock Titan
electroCore (ECOR) COO Michael Fox reports initial ownership - Stock Titan
Entry Recap: Whats the analyst consensus on electroCore Inc2026 Bull vs Bear & Accurate Intraday Trading Signals - baoquankhu1.vn
Analyst Upgrade: Is electroCore Inc stock a value trapMarket Sentiment Summary & High Conviction Investment Ideas - baoquankhu1.vn
electroCore (ECOR) Rises 7.1%: Can This Momentum Continue? - Bitget
electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last? - Yahoo Finance
Shorts Report: Will electroCore Inc outperform during market rallies2026 Sector Moves & AI Driven Price Forecasts - baoquankhu1.vn
Bond Watch: Whats the outlook for electroCore Incs sector2026 Price Swings & Reliable Price Breakout Alerts - baoquankhu1.vn
electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference - Bitget
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD - Sahm
ElectroCore (ECOR) Advances PTSD Treatment Study - GuruFocus
ElectroCore Announces First Patient Enrollmen - Moomoo
PTSD treatment study begins with 8 patients using electroCore device - Stock Titan
electroCore Inc. R (43E0.F) Q2 FY2025 earnings call transcript - Yahoo Finance
electroCore, Inc. (ECOR) stock price, news, quote and history - Yahoo Finance UK
electroCore reports study on nerve stimulation for brain injury By Investing.com - Investing.com South Africa
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD - Sahm
electroCore (ECOR) CFO Joshua Lev receives 45,000 RSU equity grant - Stock Titan
ECOR | electroCore, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
electroCore reports study on nerve stimulation for brain injury - Investing.com
ECOR PE Ratio & Valuation, Is ECOR Overvalued - Intellectia AI
Electrocore announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
ElectroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
electroCore receives two U.S. patents for nerve stimulation tech By Investing.com - Investing.com South Africa
electroCore adds a COO and sales VP, with 100,000 RSUs attached - Stock Titan
Momentum Shift: Can electroCore Inc deliver alphaQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
electroCore (ECOR) Secures Two New U.S. Patents for Vagus Nerve Modulation - GuruFocus
electroCore receives two U.S. patents for nerve stimulation tech - Investing.com
electroCore Expands Intellectual Property Portfolio - ChartMill
electroCore wins 2 U.S. patents, with terms potentially reaching 2039 - Stock Titan
Published on: 2026-03-28 12:14:09 - baoquankhu1.vn
Growth Value: Whats the analyst consensus on electroCore IncEntry Point & Precise Entry and Exit Recommendations - baoquankhu1.vn
Retail Surge: Is electroCore Inc being accumulated by smart money2026 Chart Watch & AI Optimized Trade Strategies - baoquankhu1.vn
Earnings Beat: Is electroCore Inc stock overvalued or fairly priced2026 Short Interest & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Update: Is electroCore Inc stock a value trap2026 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Retail: Is electroCore Inc stock a value trap2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
ECOR: Bioelectronic medicine leader with rapid growth, FDA-cleared devices, and expanding wellness portfolio - TradingView
Market Review: Will electroCore Inc benefit from rate cuts2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances - MSN
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
Why Is electroCore, Inc. (ECOR) Stock Down Today? - meyka.com
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
Hedge Fund Moves: Does electroCore Inc meet Warren Buffetts criteria2026 Catalysts & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Offer Predictions for electroCore FY2030 Earnings - MarketBeat
CEO Moves: Should value investors consider electroCore IncMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges - theglobeandmail.com
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) - The Globe and Mail
Electrocore Inc (ECOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):